Dynagen
Executive Summary
Former Ares-Serono Inc. President Jack Barlow joins the Cambridge, Massachusetts-based diagnostic and therapeutic R&D firm as exec VP and chairman. Barlow will continue to serve as a director of Ares-Serono. Dynagen, which raised $ 4 mil. in its initial public offering last August, recently announced a product development agreement with Wellcome Foundation Ltd. covering a rapid diagnostic test for tuberculosis.